Magnetic Resonance - Technology Information Portal Welcome to MRI Technology•
Info
  Sheets

Out-
      side
 

MRI is trending to low field magnets :
reduced costs will lead to this change 
AI will close the gap to high field 
only in remote areas 
is only temporary 
never 
 
MRI News Service:
'Pharmacyclics, Inc.'
SEARCH NEWS FOR   
 
Result: Searchterm 'Pharmacyclics, Inc.' found in 5 news
Result Pages
1
More Results: Database  (2)  Resources  (1)  
News     News Refinements:  Contrast Agents  Devices  Financial  
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
'''SUNNYVALE, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) for the company's new drug application (NDA) ...'
Friday, 21 December 2007   by www.prnewswire.com
Pharmacyclics Announces Positive Final Results of Phase 2 Trial of Xcytrin(R) Plus Radiosurgery for Brain Metastases With Occult Tumors Detected in 24% of Patients
'''CHICAGO and SUNNYVALE, Calif., June 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced final results from an open-label multi-center Phase 2 clinical trial, which indicated that Xcytrin(R) (motexafin gadolinium) ...'
Sunday, 3 June 2007   by www.prnewswire.com
Pharmacyclics Announces Presentation of Preliminary Results From Phase 2 Clinical Trial of Xcytrin(R) With Radiosurgery for Brain Metastases
'''SUNNYVALE, Calif., Nov 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced the presentation of preliminary results of an open-label multi-center Phase 2 clinical trial, which suggest that ...'
Thursday, 9 November 2006   by ir.pharmacyclics.com
Pharmacyclics Announces Pricing of Common Stock Offering
'''SUNNYVALE, Calif., Nov 07, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced the pricing of an underwritten public offering of 4,200,000 shares of its common stock at a price to the public of $4.75 ...'
Tuesday, 7 November 2006   by ir.pharmacyclics.com
Pharmacyclics Announces Results from Phase 3 Smart Trial of Xcytrin(R) for Lung Cancer Brain Metastases
'''SUNNYVALE, Calif., Dec 19, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced top-line results from its pivotal Phase 3 clinical study of Xcytrin(R) (motexafin gadolinium) Injection, for the ...'
Monday, 19 December 2005   by www.prnewswire.com
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
1
The more severe the pain or illness, the more severe will be the necessary changes. These may involve breaking bad habits, or acquiring some new and better ones.
- Peter McWilliams
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 28 April 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]